DeepMed Research

The Sidney Kimmel Comprehensive Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Employees: -

Market Cap: -

Website: http://www.hopkinsmedicine.org/kimmel_cancer_center

Clinical Trials

Breath-Hold Technique for Pancreatic Stereotactic Body Radiation Therapy (SBRT) Patients

Not Applicable

Terminated

Conditions: Pancreas Cancer

Interventions: Behavioral: Biofeedback
Behavioral: Active Breathing Control Technique

First Posted Date: 2021-04-13

Last Posted Date: 2024-06-07

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 4

Registration Number: NCT04843306

Locations: 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

Neoantigen-Targeted Vaccine Combined With Anti-PD-1 Antibody for Patients With Stage IV MMR-p Colon and Pancreatic Ductal Cancer

Phase 1

Withdrawn

Conditions: Pancreatic Cancer Metastatic
Colorectal Cancer Metastatic

Interventions: Drug: Neoantigen Vaccine with Poly-ICLC adjuvant
Drug: Retifanlimab

First Posted Date: 2021-03-16

Last Posted Date: 2023-05-09

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Registration Number: NCT04799431

Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer.

Phase 2

Recruiting

Conditions: Metastatic Pancreatic Cancer

Interventions: Drug: Nab-paclitaxel
Drug: Gemcitabine
Drug: Cisplatin
Drug: Irinotecan
Drug: Capecitabine
Drug: Pembrolizumab
Drug: Olaparib

First Posted Date: 2021-02-15

Last Posted Date: 2024-08-23

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 38

Registration Number: NCT04753879

Locations: 🇺🇸
Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States

Safety and Efficacy of Allogeneic HPV-specific T Cells in Adults With Recurrent or Metastatic HPV16+ Cancers

Phase 1

Recruiting

Conditions: HPV 16+ Recurrent or Metastatic Cancer

Interventions: Biological: CD8 reduced peripheral blood cells taken from related donors vaccinated against HPV16
Biological: Non-myeloablative allogeneic bone marrow transplant from related donors vaccinated against HPV16

First Posted Date: 2021-01-19

Last Posted Date: 2024-11-14

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 24

Registration Number: NCT04713046

Locations: 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC)

Phase 2

Recruiting

Conditions: Prostate Adenocarcinoma
Metastatic Prostate Adenocarcinoma
Castration-resistant

Interventions: Radiation: radium-223
Drug: Bipolar Androgen Therapy (BAT)

First Posted Date: 2021-01-11

Last Posted Date: 2024-06-18

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 47

Registration Number: NCT04704505

Locations: 🇧🇷
Moinhos de Vento Hospital, Porto Alegre, Brazil
🇺🇸
Amber Michalik, Baltimore, Maryland, United States

Feasibility and Efficacy of Perioperative Nivolumab With or Without Relatlimab for Patients With Potentially Resectable Hepatocellular Carcinoma (HCC)

Phase 1

Recruiting

Conditions: Hepatocellular Carcinoma

Interventions: Drug: Nivolumab
Drug: Relatlimab

First Posted Date: 2020-12-08

Last Posted Date: 2025-01-10

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 20

Registration Number: NCT04658147

Locations: 🇺🇸
The Ohio State University, Wexner Medical Center, Columbus, Ohio, United States
🇺🇸
Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States

Camostat With Bicalutamide for COVID-19

Phase 1

Terminated

Conditions: SARS-CoV Infection
Covid19
Coronavirus Infection

Interventions: Drug: Camostat Mesilate
Drug: Bicalutamide 150 mg

First Posted Date: 2020-12-03

Last Posted Date: 2023-10-06

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 6

Registration Number: NCT04652765

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

Improving Cancer Symptom Management

Active, not recruiting

Conditions: Cancer
Gastrointestinal Cancer
Lung Cancer
Thoracic Neoplasms

First Posted Date: 2020-10-19

Last Posted Date: 2024-07-16

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 100

Registration Number: NCT04589247

Locations: 🇺🇸
Bayview Medical Center, Baltimore, Maryland, United States
🇺🇸
Khinh Voong, Baltimore, Maryland, United States
🇺🇸
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States

and more 1 locations

Behavioral Weight Loss Program for Cancer Survivors in Maryland

Not Applicable

Completed

Conditions: Prostate Cancer
Gallbladder Cancer
Kidney Cancer
Bladder Cancer
Endometrial Cancer
Breast Cancer
Melanoma (Skin)
Rectal Cancer

Interventions: Behavioral: Written Weight Loss Material
Behavioral: Weight Loss App
Behavioral: Behavioral Lifestyle Weight Loss Intervention (Coaching)

First Posted Date: 2020-09-01

Last Posted Date: 2023-10-10

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 340

Registration Number: NCT04534309

Locations: 🇺🇸
Johns Hopkins ProHealth, Baltimore, Maryland, United States

Brachytherapy Innovations in Gynecologic Cancer

Withdrawn

Conditions: Gynecologic Cancer

First Posted Date: 2020-08-28

Last Posted Date: 2024-11-28

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 50

Registration Number: NCT04530019

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy